Published in Proc Natl Acad Sci U S A on April 22, 2010
γδ-T cells: an unpolished sword in human anti-infection immunity. Cell Mol Immunol (2012) 1.06
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity. Oncoimmunology (2013) 1.06
Type 1 responses of human Vγ9Vδ2 T cells to influenza A viruses. J Virol (2011) 1.05
Multifunctional immune responses of HMBPP-specific Vγ2Vδ2 T cells in M. tuberculosis and other infections. Cell Mol Immunol (2012) 1.01
Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol (2014) 0.91
Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells. Cell Mol Life Sci (2013) 0.90
Immune biology of Ag-specific γδ T cells in infections. Cell Mol Life Sci (2011) 0.89
γδ T-cell immunotherapy for lung cancer. Surg Today (2011) 0.88
Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses. Oncoimmunology (2012) 0.81
Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions. Front Immunol (2014) 0.78
Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy. Front Immunol (2014) 0.78
Tumor-activated TCRγδ⁺ T cells from gastric cancer patients induce the antitumor immune response of TCRαβ⁺ T cells via their antigen-presenting cell-like effects. J Immunol Res (2014) 0.77
Preferential Th1 cytokine profile of phosphoantigen-stimulated human Vγ9Vδ2 T cells. Mediators Inflamm (2011) 0.77
Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy. Front Immunol (2014) 0.76
Regeneration of stalled immune responses to transformed and infected cells using γδ T cells. Drug Discov Today (2014) 0.75
Human γδ T cells augment antigen presentation in Listeria Monocytogenes infection. Mol Med (2016) 0.75
Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes. Kidney Int (2017) 0.75
Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications. Front Immunol (2017) 0.75
Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8(+) T cells. Immunol Cell Biol (2017) 0.75
Age dependent differences in the kinetics of γδ T cells after influenza vaccination. PLoS One (2017) 0.75
Taking dendritic cells into medicine. Nature (2007) 11.82
Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol (2005) 5.97
NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell (2006) 5.35
Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science (2005) 4.12
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol (2007) 3.99
Professional antigen-presentation function by human gammadelta T Cells. Science (2005) 3.77
Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol (2002) 3.64
Gammadelta T cells and the lymphoid stress-surveillance response. Immunity (2009) 3.23
The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci U S A (2006) 3.19
Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev (2005) 2.96
The known unknowns of antigen processing and presentation. Nat Rev Immunol (2008) 2.85
Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol (2008) 2.82
Antigen-presentation properties of plasmacytoid dendritic cells. Immunity (2008) 2.57
Phagocytosis and antigen presentation in dendritic cells. Immunol Rev (2007) 2.49
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev (2007) 2.46
Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity (2007) 2.42
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology (2006) 1.92
Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med (1998) 1.89
Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J Exp Med (1995) 1.78
The cell biology of cross-presentation and the role of dendritic cell subsets. Immunol Cell Biol (2008) 1.69
Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci U S A (2009) 1.61
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood (2004) 1.54
Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc Natl Acad Sci U S A (2008) 1.53
IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science (2009) 1.43
gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy (2005) 1.38
Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations. Proc Natl Acad Sci U S A (2002) 1.38
Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J Infect Dis (2009) 1.37
Flexible migration program regulates gamma delta T-cell involvement in humoral immunity. Blood (2003) 1.32
Mouse gammadelta T cells are capable of expressing MHC class II molecules, and of functioning as antigen-presenting cells. J Neuroimmunol (2008) 1.25
Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc Natl Acad Sci U S A (2009) 1.24
Human gamma delta T cells: a lymphoid lineage cell capable of professional phagocytosis. J Immunol (2009) 1.18
Antiviral reactivities of gammadelta T cells. Microbes Infect (2005) 1.14
Gammadelta T cells present antigen to CD4+ alphabeta T cells. J Leukoc Biol (1998) 1.10
gammadelta T cells: novel initiators of adaptive immunity. Immunol Rev (2007) 1.09
ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II. J Immunol (2009) 1.08
Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules. Curr Opin Immunol (2006) 1.00
A sub-population of circulating porcine gammadelta T cells can act as professional antigen presenting cells. Vet Immunol Immunopathol (2002) 0.97
Expansion, reexpansion, and recall-like expansion of Vgamma2Vdelta2 T cells in smallpox vaccination and monkeypox virus infection. J Virol (2009) 0.93
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer. J Immunother (2009) 0.88
Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol (2005) 4.99
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation (2002) 3.93
Professional antigen-presentation function by human gammadelta T Cells. Science (2005) 3.77
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res (2007) 3.22
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol (2003) 2.43
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol (2004) 2.30
Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J Immunol (2006) 2.02
The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes. FEBS Lett (2004) 1.93
A skin-selective homing mechanism for human immune surveillance T cells. J Exp Med (2004) 1.91
Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat Immunol (2011) 1.66
Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci U S A (2009) 1.61
Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Cancer Res (2011) 1.54
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy. J Immunol (2007) 1.42
RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol (2008) 1.41
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med (2004) 1.40
A distinct chemokine axis does not account for enrichment of Foxp3(+) CD4(+) T cells in carcinogen-induced fibrosarcomas. Immunology (2015) 1.40
Don't count your interleukins before they've hatched. Trends Immunol (2002) 1.40
Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J Leukoc Biol (2007) 1.36
Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial. J Bone Miner Res (2013) 1.36
A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections. PLoS Pathog (2009) 1.35
Flexible migration program regulates gamma delta T-cell involvement in humoral immunity. Blood (2003) 1.32
Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun (2003) 1.28
Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells. Immunology (2003) 1.28
Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity (2005) 1.24
Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Shock (2004) 1.20
Functional characterization of GcpE, an essential enzyme of the non-mevalonate pathway of isoprenoid biosynthesis. FEBS Lett (2002) 1.17
Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr Mol Med (2007) 1.15
Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein? Arterioscler Thromb Vasc Biol (2005) 1.14
B cells alter the phenotype and function of follicular-homing CXCR5+ T cells. Eur J Immunol (2004) 1.12
Epidermis instructs skin homing receptor expression in human T cells. Blood (2012) 1.10
Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients. J Am Soc Nephrol (2013) 1.09
Murine CXCL14 is dispensable for dendritic cell function and localization within peripheral tissues. Mol Cell Biol (2006) 1.09
gammadelta T cells: novel initiators of adaptive immunity. Immunol Rev (2007) 1.09
Potent and broad-spectrum antimicrobial activity of CXCL14 suggests an immediate role in skin infections. J Immunol (2009) 1.09
Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells. J Leukoc Biol (2006) 1.08
IL-21 enhances the potential of human γδ T cells to provide B-cell help. Eur J Immunol (2011) 1.07
Failure to detect production of IL-10 by activated human neutrophils. Nat Immunol (2011) 1.05
Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis (2006) 1.03
Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection. Blood (2010) 1.02
The nonmevalonate pathway of isoprenoid biosynthesis in Mycobacterium tuberculosis is essential and transcriptionally regulated by Dxs. J Bacteriol (2010) 1.02
Chemokines: control of primary and memory T-cell traffic. Immunol Res (2005) 1.01
Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis. Ann N Y Acad Sci (2005) 1.01
Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol (2004) 1.01
Constitutive expression of CXCL14 in healthy human and murine epithelial tissues. Cytokine (2008) 0.98
γδ T-APCs: a novel tool for immunotherapy? Cell Mol Life Sci (2011) 0.98
Homing chemokines in rheumatoid arthritis. Arthritis Res (2002) 0.97
Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators? Eur J Immunol (2012) 0.96
Monocytes and gammadelta T cells: close encounters in microbial infection. Trends Immunol (2009) 0.93
Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism. Bioorg Med Chem Lett (2003) 0.93
Increased serum levels of HSP27 as a marker for incipient chronic obstructive pulmonary disease in young smokers. Respiration (2012) 0.90
Caspase-cleaved cytokeratin 18 and 20 S proteasome in liver degeneration. J Clin Lab Anal (2007) 0.87
A promising target for treatment of multidrug-resistant bacterial infections. Antimicrob Agents Chemother (2011) 0.86
Antimicrobial activities of chemokines: not just a side-effect? Front Immunol (2012) 0.86
γδ T cells predict outcome in zoledronate-treated breast cancer patients. Oncologist (2013) 0.83
HmgR, a key enzyme in the mevalonate pathway for isoprenoid biosynthesis, is essential for growth of Listeria monocytogenes EGDe. Microbiology (2012) 0.81
Receptor for advanced glycation end products and its ligands: initiators or amplifiers of joint inflammation--a bit of both? Arthritis Rheum (2006) 0.80
The human cutaneous chemokine system. Front Immunol (2011) 0.79
Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation (2004) 0.79
Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis. Immunology (2006) 0.78
Soluble ST2 protein in cardiac surgery: a possible negative feedback loop to prevent uncontrolled inflammatory reactions. Clin Lab (2005) 0.78
γδ T-cell conference 2012: close encounters for the fifth time. Eur J Immunol (2012) 0.77
Suppression of pro-inflammatory T-cell responses by human mesothelial cells. Nephrol Dial Transplant (2013) 0.76
A genetic basis for human gammadelta T-cell reactivity towards microbial pathogens. Trends Immunol (2003) 0.76
Serendipity and technical considerations for the measurement of serum heat shock protein HSP27 in patients with COPD and lung cancer. Cell Stress Chaperones (2015) 0.76
Apoptosis-specific activation markers in on- versus off-pump coronary artery bypass graft (CABG) patients. Clin Lab (2006) 0.76
Invited commentary. Ann Thorac Surg (2006) 0.75
Comment on "The vast majority of CLA+ T cells are resident in normal skin". J Immunol (2006) 0.75
An unconventional TRAIL to cancer therapy. Eur J Immunol (2013) 0.75
CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia. Am J Transplant (2003) 0.75
CDT values are not influenced by epithelial cell apoptosis in chronic alcoholic patients-preliminary results. Alcohol Clin Exp Res (2004) 0.75